Chest tube clearance system demonstrates value in cardiac surgery study ClearFlow received FDA approval for its PleuraView system in 2010. Image credit: sweet_tomato via Shutterstock.

The system minimized chest tube clogging, lowered the incidence of retained blood syndrome (RBS) and postoperative atrial fibrillation (POAF), as well as reduced median ICU hours during recovery.

Updated 7:35 p.m. A pre-clinical evaluation of a self-clearing chest tube developed by Clear Catheter Systems Inc. has demonstrated the tube that clears itself works better to drain the chest ...

A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs.

ClearFlow’s PleuraFlow Active Clearance Technology demonstrated a 64% reduction in ICU readmissions.

"Chest tube clearance system demonstrates value in cardiac surgery study" was originally created and published by Medical Device Network, a GlobalData owned brand.. The information on this site ...